These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 18774291)

  • 21. Discovery of novel 2-[2-(3-hydroxy-pyridin-2-yl)-thiazol-4-yl]-acetamide derivatives as HIF prolyl 4-hydroxylase inhibitors; SAR, synthesis and modeling evaluation.
    Hong YR; Kim HT; Ro S; Cho JM; Lee SH; Kim IS; Jung YH
    Bioorg Med Chem Lett; 2014 Jul; 24(14):3142-5. PubMed ID: 24894560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relationship between functional inhibition and binding for K(Ca)2 channel blockers.
    Benton DC; Garbarg M; Moss GW
    PLoS One; 2013; 8(9):e73328. PubMed ID: 24039913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-activity relationship study of a novel necroptosis inhibitor, necrostatin-7.
    Zheng W; Degterev A; Hsu E; Yuan J; Yuan C
    Bioorg Med Chem Lett; 2008 Sep; 18(18):4932-5. PubMed ID: 18768316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. bis-Quinolinium cyclophanes: 8,14-diaza-1,7(1, 4)-diquinolinacyclotetradecaphane (UCL 1848), a highly potent and selective, nonpeptidic blocker of the apamin-sensitive Ca(2+)-activated K(+) channel.
    Chen JQ; Galanakis D; Ganellin CR; Dunn PM; Jenkinson DH
    J Med Chem; 2000 Sep; 43(19):3478-81. PubMed ID: 11000001
    [No Abstract]   [Full Text] [Related]  

  • 25. Synthesis and evaluation of (2-phenethyl-2H-1,2,3-triazol-4-yl)(phenyl)methanones as Kv1.5 channel blockers for the treatment of atrial fibrillation.
    Blass BE; Coburn K; Lee W; Fairweather N; Fluxe A; Wu S; Janusz JM; Murawsky M; Fadayel GM; Fang B; Hare M; Ridgeway J; White R; Jackson C; Djandjighian L; Hedges R; Wireko FC; Ritter AL
    Bioorg Med Chem Lett; 2006 Sep; 16(17):4629-32. PubMed ID: 16793267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TNF-alpha-mediates neuroprotection against glutamate-induced excitotoxicity via NF-kappaB-dependent up-regulation of K2.2 channels.
    Dolga AM; Granic I; Blank T; Knaus HG; Spiess J; Luiten PG; Eisel UL; Nijholt IM
    J Neurochem; 2008 Nov; 107(4):1158-67. PubMed ID: 18823372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of K+ channels in regulating spontaneous activity in detrusor smooth muscle in situ in the mouse bladder.
    Hayase M; Hashitani H; Kohri K; Suzuki H
    J Urol; 2009 May; 181(5):2355-65. PubMed ID: 19303094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Model studies of the function of blockers on the small conductance potassium ion channel.
    Ciechanowicz-Rutkowska M; Lewinski K; Oleksyn B; Stec B
    J Pept Res; 2003 Sep; 62(3):125-33. PubMed ID: 12895274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apamin increases 5-HT cell firing in raphe dorsalis and extracellular 5-HT levels in amygdala: a concomitant in vivo study in anesthetized rats.
    Crespi F
    Brain Res; 2009 Jul; 1281():35-46. PubMed ID: 19446538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of triarylethanolamine inhibitors of the Kv1.5 potassium channel.
    Beshore DC; Liverton NJ; McIntyre CJ; Claiborne CF; Libby B; Culberson JC; Salata JJ; Regan CP; Lynch JJ; Kiss L; Spencer RH; Kane SA; White RB; Yeh S; Hartman GD; Dinsmore CJ
    Bioorg Med Chem Lett; 2010 Apr; 20(8):2493-6. PubMed ID: 20304642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis, molecular modeling, and pharmacological testing of bis-quinolinium cyclophanes: potent, non-peptidic blockers of the apamin-sensitive Ca(2+)-activated K(+) channel.
    Campos Rosa J; Galanakis D; Piergentili A; Bhandari K; Ganellin CR; Dunn PM; Jenkinson DH
    J Med Chem; 2000 Feb; 43(3):420-31. PubMed ID: 10669569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for a common pharmacological interaction site on K(Ca)2 channels providing both selective activation and selective inhibition of the human K(Ca)2.1 subtype.
    Hougaard C; Hammami S; Eriksen BL; Sørensen US; Jensen ML; Strøbæk D; Christophersen P
    Mol Pharmacol; 2012 Feb; 81(2):210-9. PubMed ID: 22046005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural determinants of lolitrems for inhibition of BK large conductance Ca2+-activated K+ channels.
    Imlach WL; Finch SC; Dunlop J; Dalziel JE
    Eur J Pharmacol; 2009 Mar; 605(1-3):36-45. PubMed ID: 19210977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of regioisomers in a series of N-substituted pyridin-4-yl imidazole derivatives by regiospecific synthesis, GC/MS, and 1H NMR.
    Wagner GK; Kotschenreuther D; Zimmermann W; Laufer SA
    J Org Chem; 2003 May; 68(11):4527-30. PubMed ID: 12762762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does small-conductance calcium-activated potassium channel contribute to cardiac repolarization?
    Nagy N; Szuts V; Horváth Z; Seprényi G; Farkas AS; Acsai K; Prorok J; Bitay M; Kun A; Pataricza J; Papp JG; Nánási PP; Varró A; Tóth A
    J Mol Cell Cardiol; 2009 Nov; 47(5):656-63. PubMed ID: 19632238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel inhibitors of the Gardos channel for the treatment of sickle cell disease.
    McNaughton-Smith GA; Burns JF; Stocker JW; Rigdon GC; Creech C; Arrington S; Shelton T; de Franceschi L
    J Med Chem; 2008 Feb; 51(4):976-82. PubMed ID: 18232633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of thieno[2,3-c]pyridines as potent COT inhibitors.
    George D; Friedman M; Allen H; Argiriadi M; Barberis C; Bischoff A; Clabbers A; Cusack K; Dixon R; Fix-Stenzel S; Gordon T; Janssen B; Jia Y; Moskey M; Quinn C; Salmeron JA; Wishart N; Woller K; Yu Z
    Bioorg Med Chem Lett; 2008 Sep; 18(18):4952-5. PubMed ID: 18755587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IKCa-channel blockers. Part 2: discovery of cyclohexadienes.
    Urbahns K; Goldmann S; Krüger J; Horváth E; Schuhmacher J; Grosser R; Hinz V; Mauler F
    Bioorg Med Chem Lett; 2005 Jan; 15(2):401-4. PubMed ID: 15603962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 3,4-Disubstituted isothiazoles: novel potent inhibitors of VEGF receptors 1 and 2.
    Kiselyov AS; Semenova M; Semenov VV
    Bioorg Med Chem Lett; 2009 Feb; 19(4):1195-8. PubMed ID: 19124243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bis-quinolinium cyclophanes: highly potent and selective non-peptidic blockers of the apamin-sensitive Ca2+-activated K+ channel.
    Conejo-García A; Campos JM
    Curr Med Chem; 2008; 15(13):1305-15. PubMed ID: 18537610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.